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Abstract
Background: Lymphatic filariasis (LF) is a so-called neglected tropical disease, currently overshadowed by higher-profile
efforts to address malaria, tuberculosis, and HIV/AIDS. Despite recent successes in arresting transmission, some 40 million
people who already have the disease have been largely neglected. This study aims to increase understanding of how this
vulnerable, neglected group can be helped.
Methods: We used purposive sampling to select 60 men and women with filarial lymphoedema (45 with filarial
elephantiasis and 15 men with filarial hydrocoele) from the south of Sri Lanka in 2004–2005. Participants were selected to
give a balance of men and women and poor and nonpoor, and a range of stages of the disease. Participants’ experiences
and the consequences of their disease for the household were explored with in-depth qualitative, semistructured
interviews.
Findings: LF was extremely debilitating to participants over long periods of time. The stigma attached to the condition
caused social isolation and emotional distress, and delayed diagnosis and treatment, resulting in undue advancement of the
disease. Free treatment services at government clinics were avoided because the participants’ condition would be
identifiable in public. Loss of income due to the condition was reported by all households in the sample, not just the
poorest. Households that were already on low incomes were pushed into near destitution, from which it was almost
impossible to escape. Affected members of low-income households also had less opportunity to obtain appropriate
treatment from distant clinics, and had living and working conditions that made hygiene and compliance difficult.
Significance: This highly vulnerable category of patients has low visibility, thus becoming marginalized and forgotten. With
an estimated 300,000 total cases of elephantiasis and/or oedema in Sri Lanka, and around 300,000 men with filarial
hydrocoele, the affected households will need help and support for many years to come. These individuals should be
specially targeted for identification, outreach, and care. The global strategy for elimination is aimed at the cessation of
transmission, but there will remain some 40 million individuals with clinical manifestations whose needs and problems are
illustrated in this study.
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Introduction
Recently, the profile of the ‘‘neglected diseases’’ [1,2] has been
enhanced by a renewed interest by policymakers, including the
new Director-General of the World Health Organization (WHO).
These diseases cause long-term morbidity, rather than high
mortality, but have been overshadowed by higher-profile efforts
to address malaria, tuberculosis, and HIV/AIDS [2]. Recent
studies show extensive and underestimated morbidity for the
neglected diseases [3], totalling around 56 million cumulative
disability-adjusted life years, which is more than for malaria and
tuberculosis [4]. Lymphatic filariasis (LF) is one of these diseases
and one of the leading causes of disability, infecting some 120
million individuals, with a further 1.3 billion people at risk [5].
Some of the best ‘‘global health buys,’’ in terms of cost per
disability-adjusted life years averted, are preventive chemotherapy
for the control of intestinal helminths, elimination of LF, and
control of onchocerciasis (the latter two programmes are based on
drug donations) [6]. Treatment costs of such chemotherapy
packages range from US$0.03 to US$1 [7–9], and it is recognised
that cost savings by integration of NTD programmes can reach as
much as 47% [10]. Economic rates of return on controlling the
neglected diseases are 15%–30% [1].
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The Global Programme to Eliminate Lymphatic Filariasis is
arguably the most rapidly expanding global health intervention
[5]. Since 2000, when nearly 12 million people were treated, the
latest WHO figures show that around 381 million people received
treatment in 2005 in 42 countries [5]. There is strong evidence to
suggest that the WHO strategy has eliminated the transmission by
mosquitoes of the causative agent Wuchereria bancrofti in Egypt
[11,12], whilst in other settings, including China, the disease is
reported to have been eliminated [13] or transmission arrested
[14].
These successes give an incomplete picture, because some 40
million people who are deformed, stigmatised, and disabled by the
disease have been largely neglected. There are, however,
promising interventions that could improve the quality of life
and reduce the level of disability of patients. If effective
interventions are to be successfully implemented, a greater
understanding is required of the consequences of the disease for
individuals and their families, the barriers they face to accessing
the care they need, and their coping strategies. Whilst there have
been studies in a number of countries on the social and cultural
aspects of LF prior to the advent of the Global Programme to
Eliminate Lymphatic Filariasis [15–17], we report here a recent
in-depth study into the social and economic impact of filarial
elephantiasis in Sri Lanka from the perspective of the people
suffering from the disease themselves. The objective of the study
was to inform future interventions and policy to help these
vulnerable, neglected people. By doing so, it responds to needs for
specific research identified in the most recent review of the
sociocultural aspects of filariasis [18].
Methods
Setting and study population
Reference to LF in Sri Lanka has been traced to the 13th
century AD [19]. Brugian filariasis, caused by Brugia malayi, was
eliminated by chemotherapy and vector control through the Anti-
Filariasis campaign, which began in 1947. The infection currently
endemic in the country is due to W. bancrofti, and is presently
confined to eight districts in the Southern, Western, and
Northwestern Provinces [20]. Our study took place in three
villages in Matara and one in Galle in 2004–2005. Further details
of the geography, ecology, and social structure of the communities
can be found in earlier published work [21].
For the qualitative study, systematic purposive sampling was
used to select 60 participants with LF for in-depth interviews
concerning their experiences and consequences of the disease.
Participants were selected by poverty status, sex, and lymphoe-
dema stage (Table 1).
Thirty of the 60 participants with LF were selected from three
villages: Polhena, Wagama, and Madihe in Matara District. A
survey in 2003 [20] identified 117 cases of lymphoedema of
varying stages, and six more were identified subsequently. Of
the total 123, 107 consented to take part in a lymphoedema
management experiment. A sample of 30 was selected from the
107 cases for qualitative interviews, to include a balance of women
and men, of poor/nonpoor status, and of lymphoedema stage.
Poverty status was identified for the initial sample selection from
the questions on occupation in the epidemiological survey, with
Author Summary
Lymphatic filariasis (LF) is a tropical disease causing
extreme swelling of the limbs and male genitals. Despite
recent successes in preventing transmission of the disease,
some 40 million people worldwide who already have the
disease have been largely neglected. We aimed to increase
understanding of how this vulnerable, neglected group
can be helped, by asking people with LF in Sri Lanka to
recount their own experiences.
Study participants reported that LF was extremely de-
bilitating over a long period of time. The social isolation
from stigma caused emotional distress and delayed
diagnosis and treatment. Free treatment services at
government clinics were avoided because the participants’
condition would be identifiable in public. Loss of income
due to the condition was reported by all households, not
only those of the poorest. Households that were already
on low incomes were pushed into near destitution by LF.
Low-income households also had fewer opportunities to
obtain effective treatment from distant clinics, and had
living and working conditions that made treatment more
difficult.
With an estimated 300,000 people with swelling of the
limbs in Sri Lanka, and around 300,000 men with swelling
of the genitals, we conclude that the affected households
will need help and support for many years to come, and
offer suggestions for immediate action.
Table 1. Sample Distribution—Interviewees by Sex, Lymphoedema Grade, and Income Category.
Stage of
Lymphoedema Descriptiona Household Income Total
Low Income Middle Income High Income
Male Female Male Female Male Female
1 Swelling is reversible overnight — 1 — — — 2 3
2 Swelling does not resolve overnight or without active
management
2 7 2 8 — 4 23
3 Swelling and presence of shallow skin folds 1 2 3 4 — 1 11
4 Presence of knobs, bumps, or protrusions, which
predispose leg to trauma
— 1 3 1 2 — 7
5 Deep skin folds whose base cannot be seen when
patient moves the leg
1 — — — — — 1
aStage of lymphoedema is taken from Dreyer et al. [22], who identify up to 7 stages. Stages 6 and 7 are more extreme than stage 5 and were not encountered in
patients in this study.
doi:10.1371/journal.pntd.0000128.t001
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participants in informal labour occupations categorised as poor
(the subsequent in-depth interviews provided detailed information
on income to define participants’ income status more directly).
The main stages of advance of lymphoedema were graded
according to the classification of Dreyer et al. [22]. Six of the
initial sample of 30 were willing to participate but were unable to
complete the full interviews, and so were omitted from the
analysis. Six replacements were selected from the 107 cases, all of
whom completed the interviews.
A further 15 participants with LF were identified from a fourth
village 10 km away from the villages in Matara District,
Unawatuna (Galle District), chosen because it had no involvement
in the lymphoedema management experiment. Key informants
helped identify households containing people with LF. House visits
were made to the named individuals and snowballing was then
used to recruit further participants for interview. A total of 47 cases
of lymphoedema were identified by this process, of which 15 were
selected to provide a mix of sex, poor/nonpoor status, and
lymphoedema stage. All agreed to participate in interviews.
A separate sample of 15 men with filarial hydrocoeles was
selected from one village in Matara District where the Medical
Officer of Health for the area considered hydrocoele to be
prevalent. Local officials acted as key informants to help identify
men with the condition. Recruitment by snowballing identified 42
cases, of whom 15 met the criteria and agreed to participate. Of
the 15 men, three had undergone surgery for their condition, while
12 had not (Table 2).
Qualitative interviews
A team of ten trained interviewers (four women and six men)
supervised by a senior project officer conducted guided interviews
with study participants in the local language, Sinhalese. Inter-
viewers worked in single-sex pairs: one conducting the interview,
the other recording the responses manually. To respect gender
sensitivities of participants, the pairs of interviewers were assigned
to interview participants of the same sex. Interview notes were
transcribed and later translated into English for analysis.
Interpretations of the data were fed back to, and refined with,
the interviewers.
All the interviewers had at least 3 y of experience of conducting
interviews according to the Affordability Ladder framework (see
below). The discussions encouraged patients to ‘‘tell their story,’’
beginning with the first symptoms to the time of the interview,
which covered periods ranging from 1 mo to nearly 30 y. Health-
seeking behaviour, costs of access to treatment, and expenditure in
the household at each stage were obtained through a historical
profile of the disease and its consequences for the household
economy. Although the participants recounted experiences that
occurred over several years, most had vivid recall of the milestones
in their illness because it had made significant marks in their lives.
Each interview took 3–4 h, some being undertaken over 2 d.
These would normally be considered exceptionally lengthy
interviews, but this situation resulted not from the researchers’
schedules but from the desire of the interviewees themselves to talk
freely and at length about their experiences. Some commented
that the interview itself provided a therapeutic release from long-
pent-up emotions, as they had been socially isolated when their
condition advanced.
Definitions of terms relating to the Sri Lankan health
system
Private practitioners. These are allopathic doctors
practicing for a fee; sometimes referred to as ‘‘general
practitioners’’—very similar to family physicians.
Indigenous practitioners. These are private practitioners of
Ayurvedic medicine. Many of them treat patients for a fee,
charging for medicine that they prescribe and often provide to the
patient at the consultation itself. Some are small-time general
physicians, while others are specialists. Among them are many
who have ‘‘inherited’’ knowledge and many who practice as
private physicians.
Direct costs. These include physicians’ fees (if private), drugs,
transport (of the patient if outpatient, or if an inpatient, costs of
visits by family members), diagnostic and other tests done in
a private hospital or outsourced when facilities are unavailable in
a government hospital
Indirect costs. Income foregone by the patient who must
access a practitioner and/or a family member who needs to
accompany the patient for treatment at a private or government
hospital or private allopathic or Ayurvedic practitioner.
Analysis
An adaptation of the affordability ladder framework [23] was
employed to organise and analyse the data. Figure 1 [24] illustrates
the basic conceptual framework. The starting point for the
Affordability Ladder analysis on the left of the figure is a perceived
or professionally defined health problem, a ‘‘need’’; in this case,
symptoms of LF. Perceived need and the consequences of that
need may vary for different types of household depending on
socioeconomic circumstances, and it is therefore important in the
analysis to look at what happens to different groups in the
population. Once the symptoms of LF are perceived by house-
holds, their experiences of seeking help for the condition may be
very different in different types of households and are represented
by the four main steps on the ladder: (1) No care; (2) informal care
and/or self-care; (3) access to and utilisation of professional care;
and (4) quality of professional care received. At each step of the
ladder there are health and social consequences and a burden of
payment as a result of the actions taken, as indicated by arrows.
The policy environment also affects people’s choices and actions in
all these steps, as the arrows denote. These are not necessarily
sequential steps: people may treat themselves with medicines or
consult an informal provider, for example, at the same time as
seeking professional help. The pattern of seeking care, however,
may differ, again depending on socioeconomic differences.
In using a systematic approach to examine the many different
aspects of the pathways from need to appropriate care, one
important aim is to identify much more closely where and why the
system is working well and where it is breaking down for different
groups in the population [23].
For the purposes of analysing the intricacies of participants’
experiences from the qualitative data, we adapted this basic
affordability ladder framework to incorporate four distinct ladders
(Figure 2). The first, a reference ladder, documented the progression
Table 2. Sample Distribution—Men with Hydrocele by
Income Category.
Status of Hydrocele Household Incomea Total
Low Middle High
No surgery 8 4 12
After surgery 0 3 3
Total 8 7 - 15
aIncome refers to current (at the time of interview) income.
doi:10.1371/journal.pntd.0000128.t002
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of the illness (historical profile of illness) as described above. A
treatment and expenditure ladder recorded the direct and indirect costs
incurred at each stage of the illness. The household economy ladder
charted the changes in the household economy after a member of
the household was identified as having LF and throughout the
duration of the illness. Lastly, the impact ladder traced the economic
and social consequences of the illness to the participant, the
household and other family members. A process of constant cross-
referencing each individual horizontally across ladders allowed
interactions and the ordering of events and consequences to be
identified. Recurring themes within and across the different types
of household (low-, middle-, and high-income) were then identified
Figure 1. Affordability Ladder Conceptual Framework. Source: [24].
doi:10.1371/journal.pntd.0000128.g001
Figure 2. The Four Ladders Framework for Analysis of Qualitative Interview Data on Lymphatic Filariasis, Sri Lanka.
doi:10.1371/journal.pntd.0000128.g002
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by reviewing the entire dataset within the four-ladders framework.
Emerging themes were noted, sorted, and grouped into main
themes. Quotations and field notes describing interviewees’
experiences with LF (presented in Boxes 1–4) are used to illustrate
the main themes identified in the analysis.
From the income information obtained in the interviews,
households were categorised as ‘‘high,’’ ‘‘middle,’’ or ‘‘low’’
income, judged against the level of incomes reported in the latest
Consumer Finance Survey of the Central Bank [25]. ‘‘Low-
income households’’ had income within the lowest three deciles
range on the national scale, ‘‘high-income households’’ had
income in the top three deciles range, and ‘‘middle-income
households’’ had incomes that fell within the 4th to the 7th deciles
range of the national scale. To minimise recall errors on
expenditures, only costs incurred in the last 3 y, and costs for
the most recent episode of inpatient care within the last 5 y, were
used. Direct and indirect costs and costs as a proportion of the
household income for participants in different types of household
were calculated.
Names of study participants have been changed to protect their
anonymity.
Ethical review
The ethical approval for the study was obtained from the
Research Ethics Committee of the Liverpool School of Tropical
Medicine and the Ethics Committee of the University of Ruhuma,
Galle, Sri Lanka. Verbal (oral) consent was given by the participants
who were invited to participate; participants were reassured that they
could withdraw from all or part of the interview at any time. The
investigators judged, on the basis of their experience, that written
consent was not obtainable because of the community-wide mistrust
of signing any official forms and the level of literacy in the
population. The ethics committees accepted this constraint. Studies
conducted by the Marga Institute in similar settings have used the
same approach, respecting the communities’ concerns.
Results
Participants’ poverty and associated way of life severely limited
their ability to prevent or cope effectively with the condition at all
stages of the disease and its treatment. At the infection stage, for
instance, poorer participants reported having to work for long
hours in contact with stagnant water, with daily exposure to
mosquito breeding places. Two common occupations for poor
women—making coir yarn and weaving thatch—involved soaking
materials in stagnant pits. Often the women had to stand chest-
high in them for hours. These pits were generally sited adjacent to
homes and were breeding places for Culex quinquefasciatus, the
vector of W. bancrofti. The ability of patients to adopt preventive
measures in the home was also severely limited. The poor could
not afford the costs involved in avoiding exposure to mosquitoes,
such as mosquito netting and repellent, and did not have the types
of houses that would keep out mosquitoes.
When we traced participants’ experiences in accessing and using
the appropriate medical care for LF with the affordability ladder,
multiple problems for households were revealed. Delayed diagnosis
was common and had irreversible consequences. Both poor and
nonpoor participants had experienced delays in diagnosis. The low-
income households were more likely to report adopting home
remedies for all types of illnesses, including lymphoedema. They
tended to seek medical treatment only when the disease seriously
affected their livelihoods, and then they tended to opt for indigenous
treatment (which would not provide an accurate diagnosis), citing
convenience, proximity, and cost as reasons.
Even low-income patients consulted private practitioners who
charged a moderate fee but had no facilities to diagnose LF. These
practitioners invariably treated only the immediate symptoms of
fever and pain, and sometimes misdiagnosed the condition. One
man, for example, had been treated for 7 y by an indigenous
practitioner for the effects of ‘‘snake bite.’’ The lymphoedema of
one pregnant woman went untreated for 9 mo because the
symptom was judged to be due to the pregnancy.
Some participants reported that they chose to go to a private
practitioner to avoid the social stigma brought about by exposure
of their affected limbs at a government clinic, despite treatment
being free at such clinics. The nonmedical costs of travel and the
indirect costs in accessing a distant government hospital were also
cited as reasons by low-income participants. The average reported
delay from first symptoms to diagnosis for low-income participants
was 3.5 y (range 2–7 y), while for middle- and high-income
participants it was 2.2 mo (range 1–4 mo).
Once diagnosed, the ability of patients to follow prescribed drug
treatment was severely constrained. Although a long course of the
drug diethylcarbamazine (DEC) (currently 84 tablets, but pre-
viously up to 120 tablets [26]) was provided free by the Anti-
Filariasis Campaign, side effects were reported by participants,
who then interrupted or gave up the treatment. One low-income
man said of the treatment, ‘‘In our daily routine and our struggle
to find work each day, how can we think of tablets?’’ Another low-
income woman commented: ‘‘Tablets can cause nausea and
stomach cramps. Then we cannot go out and do our work.’’
Travel costs and income foregone were deterrents for low-income
participants to obtaining free drugs from the government hospital.
An average direct cost of a visit to the hospital for outpatient care by
a low-income participant was Rs 215 (US$2) which was the
equivalent of 2 d of earnings for a low-income household. Inpatient
care had an average direct cost of Rs 469 (US$4.50), which was
equivalent to about 4 d of earnings for a low-income household.
Corresponding indirect costs of income foregone because of
attendance at health facilities amounted to 2 d of earnings for an
outpatient visit and 15 d of earnings for an inpatient episode. Earned
income in this population was not constant, but fluctuated fromweek
to week and was unpredictable in poor households (see Box 1).
More advanced stages of the disease were present among both
poor and non-poor participants, but there were marked differences
in the opportunities for participants from different types of household
to manage their condition and ameliorate symptoms. Middle and
high-income participants generally benefited from clean homes and
facilities to maintain personal hygiene, they reported fewer episodes
of fever and fewer injuries to the limbs, and they could afford
bandages to reduce swelling of the limbs. Poorer participants lived in
less-hygienic conditions and thus were more prone to infection, and
they could not avoid frequent lesions and wounds because of the
hazardous nature of their work. Several participants reported having
wounds that turned into suppurating sores, but out of necessity they
had continued to work with an infected limb.
More than half of the low-income participants reported that
they could not afford the cost of attending the medical centre. The
cost of frequent episodes of fever and swelling with pain was high
for low-income participants. One low-income woman with
lymphoedema had such episodes every 2 mo on average. She lost
Rs 300 (US$3) income (equivalent to 6 d of female wages) from
her thatch weaving, her husband lost the equivalent of 2 d of
income (Rs 200 [US$2]) when he stayed at home to cook and look
after the children and they spent about Rs 100 (US$1) during an
episode on Panadol and herbal applications. A total loss of Rs
500–600 (US$5–6) per episode of illness had drained their income,
putting them in debt.
Qualitative Study of Consequences of LF
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The stigma associated with LF was a dominant theme in the
accounts of most participants (see Box 1), which caused their
condition to be hidden and contributed to delay in diagnosis with
the subsequent advancement of the disease. For participants who
had social standing in their village, social stigma tended to be
a more important factor than costs in deterring them from seeking
health care. Even high-income participants who reported no
economic problems experienced mental health problems due to
the stigma they suffered within the family.
Among the male participants, hydrocoele was a source of both
physical suffering and intense social stigma. All 15 men recounted
embarrassment and stigma associated with the hydrocoele, which
had led them to hide their condition for years, until it was
advanced and severely debilitating. Most low-income men earned
their living from casual labour, mainly coconut picking, which
involved climbing to great heights. They either had to give up the
occupation, which caused loss of earnings, or continue to climb with
the hydrocoele, thus greatly aggravating the condition. One man
commented that his hydrocoele was as big as the coconuts he was
picking, but he still had to continue working with it. (see Box 2).
The social and economic consequences for the whole house-
hold, not just the participant, spanned years. Loss of income
because of the condition was reported by all households in the
sample, across all income levels—it was not just confined to the
poorest. The narratives of participants revealed reasonably well-off
households, the members of which were gradually degraded into
poverty by the condition over many years (Box 2). Equally,
households that were already poor were pushed further toward
destitution (Box 3). For some households in the sample, the
presence of a member with LF had been a hindrance to family
progress, rather than a cause of poverty, holding the family
finances back when they could have achieved an improved
standard of living. In one case, a family opted to deny the existence
of the family member with lymphoedema, leaving him in a shabby
room, given food, but unwashed and depressed, while other family
members continued to make social and economic advancement
(Box 4). A less extreme case of rejection by a high-income family
(Box 4), illustrates the mental distress, as well as economic
hardship, that was a consequence of lymphoedema.
Discussion
While LF has been recognised for some time as a leading cause
of disability globally, it has been relatively neglected by public
health policy makers. Part of the reason for this neglect may be
that the full extent of the disability associated with this disease is
hidden and not recorded in standard assessments restricted to
physical impairment. In this study, we have shown the extremely
debilitating nature of LF over a long period of time when mental
health, social, and economic consequences are taken into account
Box 1. The Economic Loss and Social Stigma
of Lymphoedema at Different Income Levels
Low-income family example.
Raja was 6 y old when he had the manifestations of LF
with recurring episodes of fever, inflammation and pain.
His mother could not always find the Rs 30 to hire a vehicle
to take him to the hospital; hence he had to walk the 2 km
to the hospital, dragging his painful leg. When such
episodes recurred, rather than go through that ordeal he
was given paracetamol (acetamenophen) to reduce the
fever, which cost Rs 10 per card of 12 tablets. When he
exposed the leg because he had to wear short trousers, he
became the butt of jokes in school. He was instructed to
visit the hospital clinic to obtain drugs every month and
keep the leg bandaged with an elastic bandage, none of
which his family could afford. He left school to become
a labourer and so the hope the family had of improving
their economic condition through education was lost. His
mother developed asthma as a result of the stress caused
by her son’s condition. The father had to constantly
interrupt his work to attend to the mother. Family income
dropped to an uncertain one of Rs 1,500 (US$15) a month,
with sporadic help from neighbours. The household was
breaking down as they could barely afford a daily meal.
High-income examples.
Sriya: ‘‘I got this big leg when I was engaged to be married.
When they heard it was filarial they backed out of the
marriage. I was earning Rs 2,500 [US$25] a month from
sewing but when the leg got worse the hospital doctor told
me I should not pedal the machine. So I lost my income as
well. When my parents died and my sister got married, only
my brother and I lived in the house. My brother married and
left the house, but my sister became widowed so came to live
with me with her child. She had no money to buy bandage
as instructed by the clinic. So I went to a house to cook.
When they saw my leg they asked me not to come there
anymore and found fault with me for hiding such a dirty
illness from them. When I get fever I cannot walk to the
hospital so I take paracetamol for two days and walk to the
hospital when I feel less pain.’’
Daya was a woman from a middle-income household: ‘‘I
was only 20 years old when my leg swelled. I could not go to
the government hospital which gave free treatment because
people would see it and shun me and my family. Without
treatment my leg got worse. I could not marry because of my
disease. I lived with my sister and her husband. I was earning
an income of Rs 3,000 [US$30]. When my leg got bad I sewed
less garments and my income dropped to Rs 2,000 [US$20]. I
could still continue to sew but my clients who saw my leg
refrained from giving me orders for stitching. I lost my
income and became dependent on my brother-in-law.’’
Box 2. The Impact of Hydrocoele in Men from
Low-Income Households
Senas’ occupation of coconut picking had to be given up
because his hydrocoele was so large and had become
infected because he had injured it while climbing. His
family was impoverished without his income. His son left
school since he had to earn from casual labour. When
Senas decided to have the surgery for the hydrocoele, his
wife began working in domestic service cooking at a house
close by. ‘‘I did not consider it demeaning—what choice
have when we are starving?’’ She was given food from that
house and a daily wage of Rs 50 [US$0.50]. This income,
together with her sons’ casual earnings, saw them through
the 3–4 mo of convalescence after surgery. Senas was able
to resume work, not in coconut picking, but in the lower-
paid job of labourer. Their household income rose to Rs
4,000–5,000 [US$40–50] a month and the son returned to
school.
Other men with hydrocoele could not afford a period off
work for surgery and recovery. Men had jobs mainly in
hard labour and coconut picking. They aggravated their
condition by continuing with picking. ‘‘I climbed with
a hydrocoele as large as the coconuts I plucked.’’ (Indrasiri,
from a family who could not afford surgery, accepted
a labourer’s job, but even that was now becoming
increasingly difficult to sustain.)
Qualitative Study of Consequences of LF
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using the affordability ladder framework. We have identified four
areas in which the clinical manifestations of W. bancrofti infection
had a major impact on the lives and livelihoods of patients and
their families in Sri Lanka.
First, the condition and its diagnosis were severely affected by
both stigma and costs. People with LF experienced the negative
responses of others to their disfigured limbs or genitals, causing
them to cover up the affected parts and, as the disease progressed,
to hide themselves away from society in general. The social
isolation from the stigma of the disease caused emotional distress,
delay in diagnosis, and treatment, resulting in advancement of the
disease beyond possible treatment.
Second, treatment services that were available—free—from
Government clinics were avoided because the participants’
condition would be publicly identifiable. Local private practi-
tioners were favoured, where their condition could be more easily
hidden. However, the consequence of this behaviour was that the
patients received less effective, or even ineffective, treatment from
private practitioners, compared with the interventions available
through the government clinics.
Third, we found devastating economic and social consequences
of the disease, for both patients and the household. The
debilitating physical symptoms restricted the kind and quantity
of work that participants could undertake, resulting in loss of
earnings and impoverishment. Households were further impover-
ished by the costs incurred in using health services (even though
the services themselves were free) and the cost of drugs, which had
to be sustained over many years—leading to a medical poverty
trap [27]. The impact of LF on productivity of the patients
themselves can be considerable. In India, for example, a estimated
US$842 million are lost to patients and households every year in
treatment costs and reduced working time through acute and
chronic disease caused by LF [7]. Other studies indicate that
productivity loss in weavers can be as high as 27% [28], and male
patients with chronic episodes of LF can lose an equivalent of 15%
of their earning capacity in any one year [29]. A study of the costs
of nonfilarial elephantiasis in Ethiopia provided similar estimates.
Direct costs of podoconiosis (nonfilarial endemic elephantiasis of
the lower leg) amounted to US$143 per patient per year with
productivity lost per patient of 45% of working days, equivalent to
monetary loss of US$63. The overall costs of this form of
elephantiasis in one zone where the population is 1.5 million was
estimated to be US$16 million per year [30].
For nearly all the participants in our sample, the incomes of other
members of the household, in addition to the participant, were
affected, either by having to forego employment to look after the
patient or by making contributions to the health care costs. Several
households in our sample had to withdraw children from school to
help with work, which would perpetuate intergenerational poverty.
Fourth, the adverse social and economic consequences were
socially patterned. While we found that households from all three
income levels had suffered reductions in income, those who were
already on low incomes were pushed into near destitution by LF,
from which it was almost impossible to escape. Low-income
households also had less opportunity to obtain effective treatment
from distant clinics, coupled with living and working conditions
that made hygiene and compliance with treatment regimes more
difficult. They were also less protected from stigma.
These findings have significant policy implications. In Sri Lanka
the prevalence of filarial elephantiasis in the population of three
villages in Matara district has been estimated to be 3% and the
prevalence of hydrocoele to be 6.2% [21]. The villages are typical
of endemic areas in terms of socioeconomic mix and occupations.
Scaling up the estimates to the whole 10 million population of the
endemic provinces gives an expected 300,000 cases of elephan-
tiasis among both women and men, and around 300,000 men with
filarial hydrocoele from a male population of approximately 4.8
million. Every afflicted person lives in a household with another
four individuals on average, all of whom may potentially suffer
social and economic consequences as a result of having a family
member with this condition. Even if the LF elimination
programme is successful in arresting transmission of the disease
so that there are no new cases, hundreds of thousands of people in
Sri Lanka will continue to suffer clinical manifestations of the
Box 4. Mental Illness Associated with Filariasis
Jamis had stage 5 lymphoedema, which was infected and
suppurating. He was a coconut picker and climbed trees
until he could no longer. He had injured his limb by
climbing. He was an embarrassment to his family. His
children had dropped out of school because they were too
poor to go to school. The sons became divers and acted as
tourist guides and soon earned an adequate income. They
built their house with tiled floors alongside the old shack.
They were progressing up the social ladder; the one
problem was their father with elephantiasis. He had been
relegated to the shack where he lived in filth and dirt
without income. He was given food and left to himself. ‘‘I
went with the tsunami but someone rescued me—why did I
not die then?’’ he said. He was depressive as a result. This
was a family that rejected the undesirable element within
it—their father—and moved ahead on a path out of
poverty and into affluence, while Jamis waited for death,
which he saw as a relief to his suffering.
Ariya, from a high-income household, had hidden her
condition from her husband and his family. ‘‘I could not
take treatment since he would find out. The condition
advanced and one day he found out my condition and
began to shun me. I stopped going out anywhere specially
where I might meet with his family. I am mentally broken
down and do not know how long I can live like this, shunned
and rejected and confined to this house.’’
Box 3. Impoverishment in Low-Income
Households
Bandu, a low-income woman aged 32, developed
lymphoedema as a young woman. She had a long period
of self-medication, because that was her usual health-
seeking behaviour. When she was diagnosed and began
treatment the tablets provoked severe reactions of nausea
and cramps, so she abandoned the treatment while her LF
advanced. Her husband had to stay away from his work to
nurse her during recurring attacks of fever and enlarged
glands. Their income dropped from Rs 2,500 (US$25) to Rs
1,500 (US$15). She lost her income of Rs 500 (US$5) from
coir work. Her daughter dropped out of school, her second
daughter failed her public examination, and they became
indebted to the grocer.
Soma had advanced lymphoedema, but did not access
the Government hospital because she was ashamed to
show her leg. She hid in her house for 15 y looking after
her widowed daughter’s children. She accepted money
from her daughter to buy penicillin and paracetamol
which she took daily to avoid fevers, but her unsightly leg
showed no improvement. She was well on the way to
become disabled and she was in despair: ‘‘what will my
poor daughter do if I cannot care for her children? She has
only me.’’
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disease and will remain trapped in poverty. The affected
households will need help and support for many years despite
transmission having been arrested.
Donors and the national government, who have to date
understandably focussed on the single-dose annual preventive
strategy where DEC and albendazole (400 mg chewable tablet
donated by GlaxoSmithKline) have been given annually since 2001,
need to re-evaluate how this neglected group can be served more
effectively. This will first require a comprehensive survey to ascertain
the number of people with elephantiasis and hydrocoele in the
endemic districts. This survey needs to be followed by a reassessment
of post-Mass Drug Distribution strategies, expansion of the
lymphoedema treatment programmes to maximise coverage for
those that remain symptomatic, and an aggressive approach to the
provision of surgical care for male patients with hydrocoele.
Direct financial support to afflicted families could be provided
under the Sri Lankan Samurdhi poverty alleviation scheme of
allowances for stipulated poor households. This approach could
then take account of the context and barriers to effective treatment
when designing and scaling up the post-Mass Drug Distribution
implementation programmes. Supporting the evaluation of clinical
interventions for the amelioration of lymphoedema will also be
important, as the interventions currently being piloted in Sri
Lanka and elsewhere need to recognise the social and economic
context and constraints on the lives of participants, and how these
differ by level of poverty.
The inclusiveness and the caring quality of a health strategy for
any given disease has to be judged by its capacity to reach out to
the most vulnerable groups affected. The present study demon-
strates one of the dilemmas that can arise in a strategy for the
control and prevention of a disease leading to chronic conditions
of ill health such as LF. The strategy itself, as in the case of Sri
Lanka, can achieve its main objectives of prevention and
elimination of the disease through large-scale interventions that
reach the great majority of the population exposed to it. However,
a highly vulnerable category of patients in advanced stages of the
disease tends to have low visibility, becoming marginalized and
forgotten. Special measures are needed to identify, reach and care
for them. As the Global Filariasis Elimination Programme reports
successes in arresting transmission, those with the condition should
not be neglected but be specially targeted for the support the
condition requires. Such support could be promoted by specific
poverty reduction policies, which would be entirely appropriate
given the evidence presented in this paper of the impact of
the disease on poor communities, and particularly at the
household level.
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